Glycemic control in patients with insulinoma treated with everolimus

New England Journal of Medicine

Volumn 360, Issue 2, 2009, Pages 195-197

  Kulke, Matthew H ^a   Bergsland, Emily K ^b   Yao, James C ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; EVEROLIMUS; GLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN KINASE B; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIETARY INTAKE; DISEASE ASSOCIATION; ENTERIC FEEDING; ENZYME ACTIVATION; FEMALE; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULINOMA; LETTER; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR VOLUME; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PANCREAS TUMOR;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; HUMANS; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; INSULINOMA; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SIROLIMUS; YOUNG ADULT;

EID: 58149385408     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0806740     Document Type: Letter

References (5)

1. Yao JC, Phan AT, Chang DZ, et al. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. J Clin Oncol 2008;26:4311-8.
2. Aspinwall CA, Lakey JR, Kennedy RT. Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 1999;274:6360-5.
3. Leibiger IB, Leibiger B, Moede T, Berggren PO. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1998;1:933-8.
4. Fuhrer DK, Kobayashi M, Jiang H. Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Diabetes Obes Metab 2001;3:393-402.
5. Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes? J Am Soc Nephrol 2006;17:2236-44.